The global neurodiagnostics market is projected to grow at a CAGR of 7.3% during the forecast period. The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. The demand for neurodiagnostic products is expected to grow due to the increasing prevalence of neurological disorders & diseases. The neurodiagnostics market is segmented on product, condition, end-user, and region.
The hospitals & surgical centers segment accounted for the largest share of the neurodiagnostics market by end-user in 2018. Based on end-user, the neurodiagnostics market is segmented into hospitals & surgical centers, diagnostic laboratories & imaging centers, neurology centers, ambulatory care centers (ACCs), and research laboratories & academic institutes. In 2018, hospitals & surgical centers accounted for the largest share of the neurodiagnostics market due to the financial capabilities of hospitals to purchase expensive equipment, such as neurodiagnostic devices.
The neurodegenerative diseases segment accounted for the largest share of the neurodiagnostics market by condition in 2018. The neurodiagnostics market, by condition, is segmented into neurodegenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and other conditions. In 2019, the neurodegenerative diseases segment is expected to account for the largest share of the neurodiagnostics market due to the increasing incidence of traumatic brain injuries, dementia, Parkinson’s disease, and Huntington’s disease, and the growing number of neurological examinations for the diagnosis of these conditions.
North America accounted for the largest share of the neurodiagnostics market in 2018. North America accounted for the largest share of the neurodiagnostics market in 2018, followed by Europe. This can primarily be attributed to the presence of a highly developed healthcare system, high adoption of innovative neurodiagnostic devices among medical professionals, full availability of advanced neurodiagnostic tools, and the large number of neurodiagnostic devices manufacturing companies that have an established base or are headquartered in the US.
Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%) • By Designation: C-level (10%), Director-level (14%), and Others (76%) • By Region: North America (40%), Europe (32%), APAC (20%), and RoW (8%)
Some of the prominent players in the neurodiagnostics market GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Hitachi, Ltd. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), and Nihon Kohden Corporation (Japan) among others.
Research Coverage This report studies the neurodiagnostics market based on product, condition, end-user, and region.It studies major factors (such as drivers and restraints) affecting market growth.
The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market.
The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.
Key Benefits of Buying the Report This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views.It also analyzes the competitive landscape; emerging segments of the neurodiagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities.
The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Our reports have been used by over 10K customers, including:
The Near Infrared Imaging Market was valued at US$ million 395.14 in 2019 and is projected to reach US$ 543.24 million by 2027; it is expected to grow at a CAGR of 4.2% from 2020 to 2027. The growth of the Near Infrared Imaging market is mainly attributed to factors such as rising number of surgical procedures worldwide, and advantages...
The Hospital Mobile mobile X-Ray market was valued at US$ 1,604.92 million in 2019 and it is projected to reach US$ 3,479.79 million by 2027; it is expected to grow at a CAGR of 10.2% during 2020–2027. The growth of the market is attributed to increasing awareness about early diagnosis and increasing rising prevalence of chronic conditions,...
211 pages •
By Asia Market Information & Development Company
• Feb 2021
China’s demand for Medical Imaging System and Equipment has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...
The veterinary diagnostics are tests, which help in determining and detecting various disorders associated with animals. The diagnostic tests are performed by taking the blood, faeces, and tissue samples, of animals. The increased pet ownerships with improving urban lifestyle and many shifting from towns to urban localities across developed...
Contrast media/contrast agents market is projected to grow at a CAGR of 3.8%. The global contrast media/contrast agents market is projected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. The contrast media market has witnessed various advancements in...
The diagnostic imaging services market is projected to grow at a CAGR of 5.1% during the forecast period. The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024. The major factors driving the growth of this market include...
The global multimodal imaging market is projected to grow at a CAGR of 4.4% during the forecast period. Multimodal imaging includes PET/CT systems, SPECT/CT systems, PET/MR systems, OCT/Fundus Imaging systems, and other multimodal imaging systems. The global multimodal imaging market is projected to reach USD 2.9 billion...
Positive diagnosis: Healthcare reform and a growing elderly population will boost revenue Abstract Diagnostic Imaging Centers The Diagnostic Imaging Centers industry is highly competitive, due both to internal pricing pressures from consolidating industry companies and volume pressure from external...
The BRIC diagnostic imaging equipment market is projected to grow at a CAGR of 9.2% during the forecast period. Diagnostic imaging is the use of electromagnetic radiation in combination with other technologies by employing diagnostic imaging devices, to produce images of internal human body structures in order to diagnose...
The global diagnostic imaging market is projected to grow at a CAGR of 5.5% during the forecast period Diagnostic imaging is the use of electromagnetic radiation in combination with other technologies by employing diagnostic imaging devices, to produce images of internal human body structures in order to diagnose accurately....
Diagnostic Imaging
X Ray System
APAC
Medical Technology Density
Medical Devices Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.